Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
Open Access
- 28 August 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 12 (1), 375
- https://doi.org/10.1186/1471-2407-12-375
Abstract
Background: Chondrosarcoma is the second most common primary sarcoma of bone. High-grade conventional chondrosarcoma and dedifferentiated chondrosarcoma have a poor outcome. In pre-clinical research aiming at the identification of novel treatment targets, the need for representative cell lines and model systems is high, but availability is scarce. Methods: We developed and characterized three cell lines, derived from conventional grade III chondrosarcoma (L835), and dedifferentiated chondrosarcoma (L2975 and L3252) of bone. Proliferation and migration were studied and we used COBRA-FISH and array-CGH for karyotyping and genotyping. Immunohistochemistry for p16 and p53 was performed as well as TP53 and IDH mutation analysis. Cells were injected into nude mice to establish their tumorigenic potential. Results: We show that the three cell lines have distinct migrative properties, L2975 had the highest migration rate and showed tumorigenic potential in mice. All cell lines showed chromosomal rearrangements with complex karyotypes and genotypic aberrations were conserved throughout late passaging of the cell lines. All cell lines showed loss of CDKN2A, while TP53 was wild type for exons 5–8. L835 has an IDH1 R132C mutation, L2975 an IDH2 R172W mutation and L3252 is IDH wild type. Conclusions: Based on the stable culturing properties of these cell lines and their genotypic profile resembling the original tumors, these cell lines should provide useful functional models to further characterize chondrosarcoma and to evaluate new treatment strategies.This publication has 32 references indexed in Scilit:
- The Use of Real-Time Cell Analyzer Technology in Drug Discovery: Defining Optimal Cell Culture Conditions and Assay Reproducibility with Different Adherent Cellular ModelsSLAS Discovery, 2011
- C-terminal domain of p16INK4a is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cellsJournal of Cellular Biochemistry, 2010
- Cartilage tumours and bone development: molecular pathology and possible therapeutic targetsNature Reviews Cancer, 2010
- Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down‐regulation and p16 overexpression inhibit cell growth in vitroJournal of Cellular and Molecular Medicine, 2009
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and OligodendrogliomasThe American Journal of Pathology, 2009
- The Clinical Approach Towards ChondrosarcomaThe Oncologist, 2008
- Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR.2005
- Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesisThe Journal of Pathology, 1999
- Prognostic factors in chondrosarcoma of bone.A clinicopathologic analysis with emphasis on histologic gradingCancer, 1977
- Characterization of a newly derived human sarcoma cell line (HT-1080)Cancer, 1974